Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes?
Open Access
- 15 February 2007
- journal article
- research article
- Published by Oxford University Press (OUP) in Brain
- Vol. 130 (3) , 816-827
- https://doi.org/10.1093/brain/awl347
Abstract
In Guadeloupe, there is an abnormally high frequency of atypical parkinsonism. Only one-third of the patients that develop parkinsonian symptoms were reported to present the classical features of idiopathic Parkinson disease and one-third a syndrome resembling progressive supranuclear palsy (PSP). The others were unclassifiable, according to established criteria. We carried out a cross-sectional study of 160 parkinsonian patients to: (i) define more precisely the clinical phenotypes of the PSP-like syndrome and the parkinsonism that was considered unclassifiable in comparison with previously known disorders; (ii) define the neuropsychological and brain imaging features of these patients; (iii) evaluate to what extent a candidate aetiological factor, the mitochondrial complex I inhibitor annonacin contained in the fruit and leaves of the tropical plant Annona muricata (soursop) plays a role in the neurological syndrome. Neuropsychological tests and MRI were used to classify the patients into those with Parkinson's disease (31%), Guadeloupean PSP-like syndrome (32%), Guadeloupean parkinsonism–dementia complex (PDC, 31%) and other parkinsonism-related disorders (6%). Patients with a PSP-like syndrome developed levodopa-resistant parkinsonism, associated with early postural instability and supranuclear oculomotor dysfunction. They differed, however, from classical PSP patients by the frequency of tremor (>50%), dysautonomia (50%) and the occurrence of hallucinations (59%). PDC patients had levodopa-resistant parkinsonism associated with frontosubcortical dementia, 52% of these patients had hallucinations, but, importantly, none had oculomotor dysfunction. The pattern of neuropsychological deficits was similar in both subgroups. Cerebral atrophy was seen in the majority of the PSP-like and PDC patients, with enlargement of the third ventricle and marked T2-hypointensity in the basal ganglia, particularly the substantia nigra. Consumption of soursop was significantly greater in both PSP-like and PDC patients than in controls and Parkinson's disease patients. In conclusion, atypical Guadeloupean parkinsonism comprises two forms of parkinsonism and dementia that differ clinically by the presence of oculomotor signs, but have similar cognitive profiles and neuroimaging features, suggesting that they may constitute a single disease entity, and both were similarly exposed to annonaceous neurotoxins, notably annonacin.Keywords
This publication has 36 references indexed in Scilit:
- Neuropathology of dementia in Parkinson's disease: A prospective, community‐based studyAnnals of Neurology, 2005
- Quantification of acetogenins in Annona muricata linked to atypical parkinsonism in guadeloupeMovement Disorders, 2005
- Atypical parkinsonism and Annonaceae consumption in New CaledoniaMovement Disorders, 2004
- Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy‐like tauopathyBrain, 2002
- Possible relation of atypical parkinsonism in the French West Indies with consumption of tropical plants: a case-control studyThe Lancet, 1999
- The Combination of Hypointense and Hyperintense Signal Changes on T2-Weighted Magnetic Resonance Imaging SequencesArchives of Neurology, 1999
- A controlled, longitudinal study of dementia in Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1992
- Criteria for diagnosing Parkinson's diseaseAnnals of Neurology, 1992
- A comparison of clinical and pathological features of young‐ and old‐onset Parkinson's diseaseNeurology, 1988
- Magnetic resonance imaging in multiple sclerosis: Decreased signal in thalamus and putamenAnnals of Neurology, 1987